Heart failure (HF), the leading cause of death in the western world, develops when a cardiac
injury or insult impairs the ability of the heart to pump blood and maintain tissue perfusion. It …

Background Few studies have assessed the extent and distribution of the blood-pressure
burden worldwide. The aim of this study was to quantify the global burden of disease related …

Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers
countermeasures aimed to restore cardiac output. These responses are compensatory at …

Orthostatic hypotension is defined as a fall in BP (ie, 30 mm Hg systolic or 10 mm Hg
diastolic BP) in response to a postural change from supine to standing. 18 Symptoms …

Natriuretic peptide (NP) levels (B‐type natriuretic peptide (BNP) and N‐terminal proBNP)
are now widely used in clinical practice and cardiovascular research throughout the world …

Background—Neurohormones are considered markers of heart failure progression. We
examined whether changes in brain natriuretic peptide (BNP) and norepinephrine (NE) over …

Background: Plasma atrial natriuretic peptide (ANP), mainly from the atrium, brain natriuretic
peptide (BNP), mainly from the ventricle, norepinephrine (NE), and endothelin-1 (ET-1) …

Background Patients with congestive heart failure (CHF) have high plasma levels of atrial
natriuretic peptide (ANP), mainly from the atrium, and brain natriuretic peptide (BNP), mainly …

Objectives: To describe the characteristics, treatment, and outcomes of active infective
endocarditis (IE) in Europe. Design: Prospective survey of medical practices in Europe …

Diabetes is an independent predictor of morbidity and mortality in patients with symptomatic
heart failure, patients with asymptomatic left ventricular dysfunction (defined as an ejection …